Oncocyte Corporation announced that Ronnie Andrews will step down from his role as a director of the company's board of directors, effective December 1, 2022. In order to ensure a smooth transition effective as of December 2, 2022, and Mr. Andrews will continue to act a consultant until February 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -4.56% | +1.38% | +17.20% |
May. 15 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.20% | 39.16M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Step Down of Ronnie Andrews as Board of Directors, Effective December 1, 2022